UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 28, 2026
Sale
Calculated transaction value
$471.24K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 27, 2026
Public filing date
Oct 28, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$591.2
Oct 27, 2026
First close after public filing
$593.54
Oct 29, 2026
Return after filing · so far
-5.31%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 807 shares @ $583.94
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000173
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$6.7M
Buys / sales
0 / 11
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Oct 27, 2026 | $828.7K |
| United Therapeutics Corp UTHR | Sale | Oct 27, 2026 | $355.23K |
| United Therapeutics Corp UTHR Current | Sale | Oct 27, 2026 | $471.24K |
| United Therapeutics Corp UTHR | Exercise | Oct 27, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Oct 27, 2026 | $51.86K |
| United Therapeutics Corp UTHR | Sale | Oct 27, 2026 | $47.43K |
| United Therapeutics Corp UTHR | Sale | Oct 27, 2026 | $275.29K |
| United Therapeutics Corp UTHR | Sale | Oct 27, 2026 | $831.67K |
| United Therapeutics Corp UTHR | Sale | Oct 27, 2026 | $776K |
| United Therapeutics Corp UTHR | Sale | Oct 27, 2026 | $940.55K |
| United Therapeutics Corp UTHR | Sale | Oct 27, 2026 | $591.75K |
| United Therapeutics Corp UTHR | Sale | Oct 27, 2026 | $413.69K |
| United Therapeutics Corp UTHR | Exercise | Oct 27, 2026 | $0 |